Stock data
Champions Oncology, Inc. (CSBR)
Champions Oncology, Inc. (CSBR) reported revenue of US$59.42M and net income of -US$1.18M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-04-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$59.42M | — | -US$1.14M | -US$1.18M | — |
| 2025 | US$56.94M | — | US$4.55M | US$4.70M | — |
| 2024 | US$50.16M | — | -US$7.36M | -US$7.28M | — |
| 2023 | US$53.87M | — | -US$5.26M | -US$5.33M | — |
| 2022 | US$49.11M | — | US$0.61M | US$0.55M | — |
Quarterly results
Data as of 2026-07-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-07-31 | US$15.23M | -US$0.43M | — |
| 2026-04-30 | US$13.84M | -US$0.70M | — |
| 2026-01-31 | US$16.56M | -US$0.28M | — |
| 2025-10-31 | US$15.04M | US$0.27M | — |
| 2025-07-31 | US$13.99M | -US$0.47M | — |
| 2025-04-30 | US$12.36M | -US$1.83M | — |
| 2025-01-31 | US$17.04M | US$4.50M | — |
| 2024-10-31 | US$13.49M | US$0.73M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.